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Abstract 
Objective: To compare the efficacy of the compuLsive Exercise Activity theraPy (LEAP) 
programme integrated with manualised cognitive behavioural therapy for anorexia nervosa 
(CBT-AN) compared to CBT-AN alone. 
 Method: Seventy-eight adults were randomised to CBT-AN, delivered with or without 8 
embedded sessions of LEAP, for a total of 34 individual outpatient sessions. Participants 
were assessed at baseline, the end of the first phase of CBT-AN (which included LEAP), 
mid-therapy, end of therapy, and at 3 and 6-months follow-up. Linear mixed effects 
modelling was used for comparing trajectories over time by group in primary outcomes of 
pathological exercise cognitions and secondary outcomes of exercise frequency, BMI, eating 
disorder (ED) symptoms, AN stage of change, anxiety/depression, and health related quality 
of life.  
Results: There were significant improvements over time in all outcomes. There were no 
significant differences between treatment groups in primary outcome measures. Fidelity and 
end-of- treatment participant satisfaction were satisfactory across both conditions.  
Discussion: CBT-AN and LEAP added to CBT-AN resulted in improved attitudes and beliefs 
towards exercise and general improvements in BMI and eating disorder psychopathology in 
people with AN.  
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Introduction 
 
Compulsive physical activity is common in people with anorexia nervosa (AN) (e.g., 
Fietz, Touyz, & Hay, 2014) and  is  associated with poorer outcomes (e.g., Steinhausen, 
Grigoroiu‐Serbanescu, Boyadjieva, Neumärker, & Winkler, 2008). The Cook et al. (2016) 
review supported incorporating psychoeducation and cognitive restructuring of exercise 
beliefs into AN treatment but empirical research is lacking.  
A cognitive behavioural model of compulsive exercise (Meyer, Taranis, Goodwin & 
Haycraft, 2011) has proposed a re-conceptualisation of exercise as having multiple 
maintaining factors including affect regulation. The present trial aimed to evaluate a 
cognitive behavioural therapy (CBT) for exercise embedded in the treatment of AN based 
upon this model, namely compuLsive Exercise Activity theraPy (LEAP). Primary outcomes 
were reduced pathological exercise cognitions. Secondary outcomes were reduced levels of 
driven exercise and eating psychopathology, improved weight gain, motivation to change, 
and health related quality of life (HRQoL).  
Method 
Design 
This 3-site 2-armed parallel RCT recruited participants from clinics and community 
advertising.  Eligibility procedures included an exercise frequency measure, body mass index 
(BMI; kg/m
2
), the Eating Disorder Examination (EDE; Fairburn, Cooper, & O’Connor, 
2008), the Mini-International Neuropsychiatric Interview (MINI; Sheehan, & Lecrubier, 
2010) and medical assessment.   
Those who met eligibility criteria and consented were randomised using an internet 
website with stratification by site, restricting vs. binge-eating/purging AN subtype, current 
use of  psychotropic(s), and having had psychotherapy for AN within past 12 months. Only 
4 
 
 
the allocating investigator (PH) had access to randomisation group data. Assessors and 
participants were blind to group. Participants were informed they were having alternate forms 
of CBT and of the rationale for blinding. At end of treatment all were asked: "Do you think 
you were in the new (novel) or existing (control) randomised condition for therapy?".  
The two treatment groups were:  34 individual sessions over 8-10 months of 
manualised CBT for AN (CBT-AN; Pike, Walsh, Vitousek, Wilson, & Bauer, 2003) or two 
sessions of CBT-AN, eight sessions of LEAP treatment embedded within CBT-AN sessions, 
and then 24 further sessions of CBT-AN. Therapy was twice weekly for four weeks and 
weekly thereafter with 3 and 6 months follow-up delivered by CBT-trained specialist 
therapists.  
Participants   
Eligibility criteria were: > 18 years, meeting DSM-5 (APA, 2013) criteria for AN, 
BMI 14 - 18.5, and reporting at least one exercise activity during the previous month 
Exclusion criteria were: a diagnosis of psychosis or bipolar disorder; and/or a high level of 
suicide risk; and/or medical compromise precluding outpatient care; and/or DSM-5 
substance use disorder associated with ‘clinically significant impairment or distress’ (APA, 
2013). 
Ethics approvals were obtained from: the Western Sydney University Human 
Research Ethics Committee (HREC; lead committee) Protocol Approval number H7732; 
University of Sydney HREC Protocol Approval number 2012/684; the National Research 
Ethics Service in the UK, Health Research Authority Approval number 10/H0406/25; and the 
Institutional Review Board at Columbia University Protocol Approval number 1205012397.  
Assessment measures 
Eating disorder features and BMI were assessed using the EDE v6 (Fairburn, Cooper 
& O’Connor, 2008) interview. To reduce participant burden the EDE was administered at 
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baseline, end of treatment and 6 months follow-up. Cronbach’s α for the EDE global score 
in the present study was .90.   
Exercise activity at screening used the validated Exercise Participation Screening 
Questionnaire (EPSQ) (Davis, Kennedy, Ravelski, & Dionne 1994, Young et al., 2017). 
Participants were asked to report the number of weeks of engaging in any exercise in the 
past 4 weeks), the average number of exercise sessions per week, and the average duration 
of each session. Exercise frequency was computed by multiplying number of weeks x 
number of sessions per week x average duration in 30 minute blocks.  
Exercise cognitions: These were assessed with the self-report 21-item Exercise 
Beliefs Questionnaire (EBQ), the 24-item Compulsive Exercise Test (CET), and the 8-item 
Commitment to Exercise Scale (CES).  The EBQ (Loumidis & Wells, 1998) measures 
maladaptive beliefs about exercise in four domains: ‘social desirability’; ‘physical 
appearance’; ‘mental and emotional functioning’; and ‘vulnerability to disease and aging’ 
with established psychometric properties (Young et al., 2017). Cronbach α for the EBQ total 
was .95. The CET (Taranis, Meyer & Touyz, 2011) measures core features of the LEAP 
model for compulsive exercise: Avoidance and Rule-Driven Behaviour, Weight Control , 
Mood Improvement, Lack of Exercise Enjoyment, and Exercise Rigidity. It has established 
psychometric properties (Young et al., 2017). Cronbach’s α of the CET-total was .92. The 
CES (Davis, Brewer, & Ratusny, 1993) measures obligatory aspects of exercise behaviour 
(e.g., making up for missed exercise sessions).  It has robust psychometrics (Young et al., 
2017) and Cronbach α in this study was .95. 
Health Related Quality of Life (HRQoL) was assessed with the widely used and 
validated Short Form-12 item Health Status Questionnaire v2 (SF-12; Ware, Kosinski & 
Keller, 1996). Cronbach’s α for the overall scale was .88. Eating Disorder Quality of Life 
(EDQoL; Engel et al., 2006) was assessed with this disorder specific 25-item measure. It has 
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robust psychometric properties and Cronbach’s α for the overall scale was .93. Depression 
and anxiety symptoms were assessed with the Kessler-10 item scale (K-10). It has robust 
psychometrics (Andrews & Slade, 2001). Cronbach’s α was .92.  
Motivation to change was assessed with the validated 20-item AN Stages of Change 
Questionnaire (ANSOCQ; Rieger, Touyz & Beumont, 2002) designed according to the 
Prochaska stages of change model was used. Cronbach’s α for the overall scale was .91. 
End of treatment participant’s satisfaction with therapy was assessed with the 8-item 
Client Satisfaction Questionnaire (CSQ; Larsen, Attkisson, Hargreaves, & Nguyen, 1979). It 
has a high degree of internal consistency and has been found to correlate with therapists’ 
assessment of client satisfaction and with early treatment drop out. Cronbach’s alpha was 
.93, n=48. Participants were also asked to rate treatment suitability, perceived success of 
treatment, and if they would recommend it to others on a scale 1-9 (higher scores being a 
more positive perception). 
Interventions 
In LEAP, the aim is to equip individuals with knowledge and skills to enable them to 
regain control of their exercise behaviour in order to participate in age-, goal- and health-
status appropriate exercise.  LEAP consists of eight sessions embedded in 50-minute duration 
CBT-AN sessions. It incorporates behavioural experiments to reduce driven exercise and 
specific cognitive activities related to the individual’s views on the maintenance of excessive 
exercise; education about what constitutes ‘healthy’ exercise; cognitive skills and strategies 
necessary to challenge maladaptive attitudes, beliefs and behaviours toward exercise; 
alternative (adaptive) emotion coping strategies; and relapse prevention. CBT-AN is an active 
three phase treatment aimed at restoring weight and normal eating habits by challenging 
underlying beliefs and thoughts through cognitive restructuring and behaviour change (Pike, 
Walsh, Vitousek Wilson, & Bauer, 2003). 
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 Therapists and supervisors (MLP, PH, ST) were trained in LEAP and CBT-AN by 
CM, JA, and KP with a three-day training.  Each therapist conducted two pilot supervised 
34 session treatments.  Weekly teleconference supervision was conducted and therapists 
also met onsite to review patients’ progress. All sessions were audiotaped and therapist 
fidelity was assessed by an audit conducted by KP.  
Regular follow-up medical assessments by a doctor blind to group were required and 
if indicated participants with medical compromise were hospitalised returning to the 
outpatient treatment trial provided this was less than 21 days. In addition to the Study 
Executive Committee an independent Data Management Safety Board (DMSB) of three 
independent clinical trial researchers met once to perform an interim futility analysis when 
over 50% of participants were recruited. At this time the advice was for the trial to proceed. 
Statistics 
Data were cleaned and inspected for normality. Using SPSS version 20, baseline 
univariate between-group tests (parametric and non-parametric) were done to compare 
groups at baseline on outcome variables and demographic data, with alpha set to .01 
because of multiple comparisons.  
STATA was used for linear mixed effects modelling with maximum likelihood 
imputation to test for between-group differences in the continuous outcome measures.  
These analyses were conducted by RC who was blind to group assignment. Estimates of 
effect size (Cohen’s d) were calculated. All tests were 2-tailed. 
An a priori power analysis was based on a standardized effect size of moderate 
improvements on the exercise questionnaires (assessing primary outcomes) of 0.5-0.6, with 
α (one sided) = .05, β = .2, the estimated minimum n per group was 51 -36.  
Results 
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Seventy-eight adults were randomised (see Table 1): Sydney (n=28), Leicester (n=40) 
and New York (n=10). Between treatment group and site features are reported in Table 1 and 
Additional online Table 1. Participants in the UK were older than others. There were no other 
significant site differences (all p>.01). 
 
INSERT TABLE 1 ABOUT HERE 
Participant flow (see Additional online Figure 1): Thirty-five percent of those eligible 
to participate were randomized.  Eighty-seven percent completed LEAP and the comparable 
CBT-AN treatment period. Fifty-five percent completed 75% of therapy sessions. 
Assessment attrition at 6-months was 45%; higher in the LEAP arm (53% vs 38%) 
Between group outcome analyses: Primary and secondary outcome data are presented 
in Table 2.  
INSERT TABLE 2 ABOUT HERE 
There was a significant effect of time for all outcomes. There were no significant 
effects of group by time interactions with the exception of BMI (see also Additional online 
Figure 2). At 6-months 20 (52.6%) in the LEAP and 15 (37.5%) in the CBT-AN arm had 
BMI>18.5 and there were 22 (28%) people in “remission”, i.e. scoring within 1 SD of 
community norms for Global EDE (Mond, Hay, Rodgers, Owen, & Beumont, 2004) BMI 
>18.5 (n= 11 in each treatment group).  
Fidelity: Three raters had mean inter-rater agreement range of 68.63-96.25 on CBT 
components. Out of a total 56 rated sessions, only 3 sessions (5.4%) were rated as not 
conforming to standard CBT protocol.  In 94.6% of sessions (53/56), clinicians were 
considered to have adhered to the basic overall structure and principles of the therapy.   
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Client satisfaction: At end of treatment the mean overall CSQ score was 3.39 (SD .56, 
range 3.12-3.53, n=48, maximum score of 4) and this did not differ between treatment groups 
(t(46)=1.175, p=.862). The mean scores for the therapy’s suitability was 7.29 (SD 1.76, 
n=49), perceived success was 6.43 (SD=1.99, n=49), and recommendation to others was 7.49 
(SD=1.77, n=49) (maximum scores of 9 for these three ratings).  
Blinding: Thirty-nine (50%) participants answered the question on blinding, 14 
considered they were in the novel group, 18 in the control group and seven did not know. 
Eleven (61%) correctly identified they received novel therapy and 14 (66%) correctly 
identified that they received the standard therapy.  Overall 25 (64%) correctly identified their 
treatment group.  
Discussion 
In this study there was improvement over time for all outcomes. The severity of core 
compulsive exercise features on the CET improved  to the levels of Australian young women 
in the community (Taranis, Touyz, & Meyer, 2011) and patients  “recovered” from AN 
(Young, Rhodes, Touyz &  Hay, 2015).  There were no significant between group differences 
with the exception of BMI. However, the pattern of change was difficult to interpret in that 
BMI increased more rapidly during treatment in CBT-AN than in LEAP, but at 6-months  
months follow-up BMI was higher in the LEAP compared to the CBT-AN group. Also, one 
significant interaction out of 11 measures is nearing chance. Thus caution must be applied to 
the result.  
Limitations of the study were that participants had a range of levels of compulsive 
exercise (albeit the mean CET was similar if not higher than reported in people with eating 
disorders) and attrition which was particularly high at the six month follow-up. Further, 
although minimal, CBT-AN also addresses exercise minimally with CBT approaches (1-2 
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sessions in the later phase of CBT-AN) and 64% participants were correct in guessing their 
treatment assignment, both of which may have reduced differences between groups. 
Strengths were maintenance of treatment fidelity, use of multiple sites which improves 
generalisability, and use of robust measures. 
In conclusion, this study adds to previous literature regarding the incorporation of 
physical activity and cognitive restructuring of attitudes towards compulsive exercise into 
AN treatment.  Clinicians may choose to use CBT-AN with or without LEAP for people with 
anorexia nervosa. 
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Table 1 
Participant demographic and clinical features by randomisation group 
 LEAP CBT-AN  
Feature n M (SD) M (SD) t (df) p Cohen’s d 95% CI 
Age/years 78 26.1 (7.9) 28.6 (10.3) 1.16 (76) .25 .27 [-.18, .72 ] 
Onset AN 
/years 
72 16.7 (4.9) 20.2 (9.4) 
 
1.94 (70) .06 .45 [.001, .90] 
Lowest adult 
weight /kg 
76 40.7 (4.3) 41.7 (5.1) 
 
-.91 (74) .37 .21 [-.23, .66] 
  Mdn (IQR)  U (Z)  η2†  
EPSQ total  78 130 (16-336) 180 (62-314) 685 (-.75) .45 .17 - 
  n (%)  χ2 (df=1) p RR  
Male 78 2 (5.0%) 2 (5.3%) .003 1.00†† 1.05 [.16, 7.10] 
Marital status- 
Married  
78 8 (21%) 13 (33%) 
 
1.30 
 
.26 .65 [.30, 1.39] 
University 
education 
78 19 (50%) 22 (55%) 
 
.20 
 
.66 .91 [.60, 1.40] 
Employed 78 19 (50%) 28 (70%) 3.27 .12 .71 [.49, 1.04] 
Restrictive  
sub-type AN 
78 24 (63%) 26 (65%) .03 
 
.87 .97 [.70, 1.36] 
 
Note: CI = confidence interval; EPSQ = Exercise Participation Screening Questionnaire; RR 
= Risk Ratio; AN = Anorexia Nervosa; Employed  = paid employment or home-maker;  
†
 Eta squared ††Fisher’s exact test
15 
 
 
Table 2  
Primary and secondary outcomes between groups with between group effect size (Cohen’s d) at each time point and linear mixed effects 
modelling analyses with maximum likelihood imputation of complete sample (n=78). 
 Baseline T1 
10 weeks 
LEAP end 
T2 
20 weeks 
Mid therapy 
T3 
34 weeks 
End therapy  
 
T4 
3 months 
follow up 
T5 
6 months 
follow-up  
Time Group x time 
Outcome Group M (SD) F 
(df) 
p F 
(df) 
p 
Compulsive  
Exercise Test  
LEAP  
 
15.7 (4.3) 14.9 (4.4) 12.5 (4.3) 11.9 (5.5) 13.2 (4.5) 12.8 (5.1) 44.46 
(1,383.31) 
<.001 3.71 
(1, 310.00) 
.06 
CBT-AN 16.8 (4.5) 15.1 (5.4) 14.9 (5.1) 14.1 (4.8) 13.9 (4.8) 13.7 (5.1) 
Cohen’s d .25 .04 .51 .43 ..15 .18 
95%  CI [-.20, .70] [-.40, .49] [.06, .96] [-.02, .88] [-.29, .60] [-.27, .62] 
Exercise Beliefs 
Questionnaire  
LEAP 45.6 (21.2) 37.5 (23.8) 30.2 (20.4) 27.1 (21.1) 29.6 (27.4) 29.3 (20.8) 19.15 
(1, 56.25) 
<.001 2.80 
(1,356.25 
.10 
CBT-AN 46.0 (24.3) 43.7 (27.4) 44.9 (25.8) 40.0 (27.5) 39.4 (27.5) 44.0 (27.9) 
Cohen’s d .02 .24 .63 .53 .36 .60 
95%  CI [-.43, .46] [-.20, .69] [.18, 1.09] [.07, .98] [-.09, .81] [.14, 1.05] 
Commitment to  
Exercise Scale  
LEAP 60.8 (27.9) 46.5 (26.4) 34.8 (25.0) 36.8 (26.5) 36.0 (29.7) 31.3 (24.2) 56.17 
(1, 373.34) 
<.001 .90 
(1,373.34) 
.34 
CBT-AN 70.1 (26.7) 60.9 (30.8) 58.5 (30.4) 47.8 (30.4) 50.5 (30.4) 51.9 (32.4) 
Cohen’s d .34 .51 .85 .39 .48 .72 
95%  CI [-.11, .79] [.06, .96] [.39, 1.31] [-.06, .83] [.03, .93] [.26, 1.18] 
Table 2 contd overpage 
16 
 
 
Table 2 contd 
 Baseline T1 
10 weeks 
LEAP end 
T2 
20 weeks 
Mid therapy 
T3 
34 weeks 
End therapy 
 
T4 
3 months 
follow up 
T5 
6 months 
follow-up 
Time Group x Time 
Outcome Group M (SD) F 
(df) 
p F 
(df) 
p 
Psychological 
distress, 
Kessler-10 
questionnaire 
LEAP 31.5 (9.2) 30.1 (9.1) 27.9 (9.8) 24.3 (8.4) 23.3 
(7.8) 
23.2 (7.6) 8.98, 
(1,  379.82) 
<.01 1.23 
(1, 379.82) 
.27 
CBT-AN 30.4 (9.9) 27.8 (10.6) 26.8 (9.5) 22.3 (9.8) 22.0 
(7.5) 
22.5 (8.2) 
Cohen’s d -.12 -.23 -.11 -.22 -17 -.09 
95%  CI [-.56, .33] [-.68, .21] [-.56, .33] [-.66, .23] [-.62, 
.28] 
[-.53, .36] 
Anorexia 
Nervosa Stage 
of Change  
 
LEAP 2.4 (.6) 2.7 (.8) 3.0 (.8) 3.0 (.9) 2.9 (1.1) 2.7 (1.9) 26.89 
(1, 385.21) 
<.001 16.23 
(1, 385.21) 
.52 
CBT-AN 2.4 (.6) 2.8 (.8) 2.9 (.7) 3.3 (1.0) 3.2 (1.3) 3.4 (1.5) 
Cohen’s d 0 .13 .13 .32 .25 .41 
95%  CI [-.44, .44] [-.32, .57] [-.58, .31] [-.13, .76] [-.20, 
.69] 
[-.04, .86] 
EDQoL LEAP 1.6 (.6) 1.5 (.6) 1.4 (.7) 1.1 (.8) 1.2 (.8) .9 (.7) 36.54 
(1, 85.04) 
<.001 4.02 
(1, 385.04 
<.05 
CBT-AN 1.8 (.8) 1.5 (.7) 1.4 (.9) 1.0 (1.0) 1.0 (.8) 1.1 (.9) 
Cohen’s d .28 0 0 -.11 .25 ..25 
95%  CI [-.16, .73] [-.44, .44] [-.44, .44] [-.55, .33] [-.70, 
.20] 
[-.20, .69] 
 
Table 2 contd overpage 
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Table 2 contd 
 Baseline T1 
10 weeks 
LEAP end 
T2 
20 weeks 
Mid therapy 
T3 
34 weeks 
End therapy 
 
T4 
3 months 
follow up 
T5 
6 months 
follow-up 
Time Group x Time 
Outcome Group M (SD) F 
(df) 
p F 
(df) 
p 
HRQoL  
MCS  
LEAP 28.7 (10.9) 32.1  (11.5) 33.4 (12.5) 35.6 (10.0) 34.2 (11.0) 37.8 (10.9) 19.367 
(1, 381.96) 
<.001 .98 
(1, 381.96) 
.32 
CBT-AN 29.5 (13.0) 33.3 (11.8) 33.4 (12.4) 39.1 (11.4) 39.9 (11.6) 40.2 (13.1) 
Cohen’s d ..07 .10 0 .33 .50 .20 
95%  CI [-.38, .51] [-.34, .55] [-.44, .44] [-.12, .77] [.05, .96] [-.25, .64] 
HRQoL  
PCS 
LEAP 47.7 (9.2) 46.2 (10.5) 48.2 (9.4) 51.2 ( 10.8) 51.2 (6.8) 51.4 ( 9.4) 8.98 
(1, 379.82) 
.003 1.23 
(1, 379.82) 
.27 
CBT-AN 46.2 (11.1) 48.3 (11.5) 49.6 (9.1) 51.2 ( 9.6) 50.2  (8.5) 48.9 (11.3) 
Cohen’s d -.15 .19 .15 0 .-13 -.24 
95%  CI [-.59, .30] [-.26, .64] [-.29, .60] [-.44, .44] [-.57, .32] [-.69, .21] 
EDE  
Driven 
Exercise 
LEAP 49.24 (30.12) n.a. n.a. 24.05 (31.34) n.a. 23.47 (21.29) 40.68 
(1, 116.90) 
<.001 .856 
(1, 116.90) 
.36 
CBT-AN 58.20 (27.39) n.a. n.a. 38.27 (25.21) n.a. 35.70 (24.93) 
Cohen’s d .31 n.a. n.a. .50 n.a. .53 
95%  CI [-.14, .76] n.a. n..a [.05, .95] n.a. [.07, .98] 
 
Table 2  contd overpage 
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Table 2 contd  
 
 Baseline T1 
10 weeks 
LEAP end 
T2 
20 weeks 
Mid therapy 
T3 
34 weeks 
End therapy 
 
T4 
3 months 
follow up 
T5 
6 months 
follow-up 
Time Group x Time 
Outcome Group M (SD) F 
(df) 
p F 
(df) 
p 
EDE Body 
Mass Index 
(kg/m2) 
LEAP  
 
16.58 (1.04) n.a. n.a. 16.99 (4.04) n.a. 19.04 (3.40) 7.92 
(1, 99.96) 
.01 6.48 
(1, 99.96) 
.01 
CBT-AN 16.47 (1.20) n.a. n.a. 18.49 (2.90) n.a. 18.12 (2.98) 
Cohen’s d -.10 n.a. n.a. .43 n.a. -.29 
95%  CI [-.54, .35]   [-.02, .88]  [-.74, .16] 
Global EDE 
score 
LEAP 3.54 (1.29) n.a. n.a. 2.28 (1.32) n.a. 2.08 (1.77) 34.37 
(1, 104.56) 
<.001 .38 
(1, 104.56) 
.54 
CBT-AN 3.18 (1.29) n.a. n.a. 2.16 (1.42) n.a. 1.99 (1.47) 
Cohen’s d -.28 n.a. n.a. -.09 n.a. -.06 
95%  CI [-.73, .17]   [-.53, .36]  [-.50, .39] 
 
Note: CI = confidence interval; EDQoL = Eating Disorder Quality of  Life Questionnaire; HRQoL MCS =  Health Related Quality of Life 
Mental Health Component Score on the Short Form 12 item  questionnaire; HRQoL PCS = Health Related Quality of Life Physical  Health 
Component Score on the Short Form 12 item  questionnaire; EDE = Eating Disorder Examination; n.a. = not applicable
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Additional online Table: Site group demographic, and primary outcome comparisons 
 Australia (Aus) 
N=28 
UK n=40 USA n=10   
Feature n Median (IQ range) K-W H, 
df=2, p 
Post 
hoc 
p<.05 
Age/years 78 27.5 (23.5-
31.7) 
22.2 (19.6-26.5) 36.1 (23.2-
54.6) 
9.42, <.01 UK<Aus, 
USA 
Age perceived 
onset AN 
/years 
 
72 16.0 (14.0-
20.5) 
16.0            
(14.0-20.3) 
20.0 (17.0-
30.0) 
2.23, .33 - 
Lowest adult 
weight /kg 
76 39.5 (36.8-
42.0) 
41.9 (39.5-45.0) 42.1 (39.0-
44.1) 
4.44, .11 - 
 
EPSQ total 
score 
78 86 (44-311) 168 (54-365) 216 (184-283) 2.84, .24 - 
Compulsive  
Exercise Test 
(CET) 
78 15.55 (12.40-
18.22) 
17.37 (14.68-
19.63) 
18.99 (15.03-
19.71) 
6.38, .04 - 
Exercise 
Beliefs 
Questionnaire 
(EBQ) 
78 48.96 (30.78-
64.36) 
46.80 (24.12-
59.60) 
58.60 (30.10-
85.34) 
2.47, .29 - 
Table contd on next page 
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Additional online Table contd: Site group demographic, and primary outcome 
comparisons 
  Australia (Aus) 
N=28 
UK n=40 USA n=10   
Feature n Median (IQ range) K-W H, 
df=2, p 
Post 
hoc 
p<.05 
Commitment 
to  Exercise 
Scale (CES) 
78 65.09 (41.70-
86.94) 
70.13 (54.75-
90.88) 
85.06 (59.75-
87.50) 
1.17, .56 - 
EDE BMI 
kg/m
2
 
78 16.40 (15.60-
17.24) 
16.80 (15.60-
17.39) 
17.36 (16.71-
17.80) 
5.03, .08 - 
Global EDE 
score 
78 3.0 (2.1-3.7) 3.9 (3.1-4.8) 2.4 (.8-4.2) 5.71, .06 - 
EDE Driven 
exercise 
78 54.5 (10.5-
79.5) 
60.0 (34.0-81.5) 73.0 (67.0 -
84.0)  
3.58, .17  - 
  n (% those within those with  the feature) χ2, df=2, p  
Male 78 2 (50%) 1 (25%) 1 (25%) 1.289, .53 - 
Marital status- 
Married  
78 9 (43%) 8 (38%) 4 (19%) 2.231,.33 - 
University 
level education 
78 18 (44%) 16 (39%) 7 (17%) 5.295,.07 - 
In paid 
employment/ 
homemaker 
78 19 (40%) 22 (47%) 6 (13%) 1.137, .57 - 
Restrictive 
sub-type 
78 18 (36%) 24 (48%) 8 (16%) 1.391, .50  
EPSQ = Exercise Participation Screening Questionnaire 
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Additional online Figure 1. Participant flow  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Note: None were returned to the study after less than 3 weeks of hospitalisation. 
A=Australia, UK=United Kingdom, USA=United States of America , LEAP =The 
compuLsive Exercise Activity TheraPy added to Cognitive  Behaviour Therapy for Anorexia 
Nervosa arm of the trial, CBT-AN = The Cognitive  Behaviour Therapy for Anorexia 
Nervosa without LEAP arm  of the trial 
Assessed for eligibility (n=574) 
324 UK plus 211 A plus 39 US 
Excluded (n=496) 
  296 did not meeting inclusion criteria  
(n=72A , 213 UK, 11 USA) 
   144 declined to participate  
(n=97 A, 30 UK, 17 USA ) 
   56 had other reasons /incomplete 
assessment/other treatment service  
(n=14A, 41UK,  1 USA) 
 
Allocated to LEAP + CBT-AN (n=38) 
 33 Completed all LEAP sessions  87% 
 21 Completed 75% LEAP+CBT-AN 
sessions 55% 
 17 Discontinued intervention* (1 too busy, 
4 admitted hospital, 9 non-engaged, 1 
therapy break, 2 unknown) 45% 
Allocated to CBT-AN (n=40) 
 35 Completed all therapy sessions 1-10 
AN 87% 
 22 Completed 75% CBT-AN sessions 
55% 
 18 Discontinued intervention* (n=14 
non-engaged, 2 admitted to hospital, 1 
therapy break, 1 unknown) 45% 
 
Allocation 
Follow-Up & Analyses 
78 Randomized  
Data Analysed n=38 
 
Assessed: 
End of LEAP   n=31 
End of Treatment n=24 
6 months   n=18 
 
Data Analysed n=40 
 
Assessed: 
End 10 weeks   n=32 
End  of Treatment         n=24  
6 months     n=25 
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Additional online Figure 2.  Body mass indices (BMI) for each intervention group over 
time with maximum likelihood imputation of complete sample (N=78). 
 
 
BMI (kg/m
2
) as measured during Eating Disorder Examination,  
Error bars represent 95% CI.  
 
